1. Inflammation Research Association Proceedings of the Seventh International Conference

   Editorial Pages: S113 - S113

2. Intra-articular injection of stromelysin into rabbit knees as a model to evaluate matrix metalloprotease inhibitors

   • R. L. Goldberg
   • D. Parker
   • E. O'Byrne

   I. Cartilage degradation and osteoarthritis Pages: S115 - S116

3. Oral administration of a matrix metalloproteinase inhibitor, CGS 27023A, protects the cartilage proteoglycan matrix in a partial meniscectomy model of osteoarthritis in rabbits

   • E. M. O'Byrne
   • D. T. Parker
   • V. S. Ganu

   I. Cartilage degradation and osteoarthritis Pages: S117 - S118

4. Stromelysin expression in IL-1β stimulated bovine articular cartilage explants

   • S. Wertheimer
   • S. Katz
   • A. C. Hanglow

   I. Cartilage degradation and osteoarthritis Pages: S119 - S120

5. Molecular cloning and characterization of rabbit TIMP2

   • S. J. Wertheimer
   • S. L. Katz

   I. Cartilage degradation and osteoarthritis Pages: S121 - S122

6. Effects of a protein kinase C inhibitor (PKCI) on the development of adjuvant-induced arthritis (AA) in rats

   • M. DiMartino
   • C. Wolff
   • P. Nambi

   I. Cartilage degradation and osteoarthritis Pages: S123 - S124

7. The influence of a peptide sequence from PF-4 (CT-112) on type II collagen-induced arthritis in mice

   • P. H. Wooley
   • J. D. Whalen
   • D. F. Counts

   I. Cartilage degradation and osteoarthritis Pages: S125 - S126

8. Overexpression of the NC₄ domain of type IX collagen induces osteoarthritis in mice

   • H. B. Haimes
   • P. A. Jimenez
   • B. R. Olsen

   I. Cartilage degradation and osteoarthritis Pages: S127 - S128

9. Induction of osteoarthritis in guinea pigs by transection of the anterior cruciate ligament: Radiographic and histopathological changes

   • P. A. Jimenez
   • P. M. Harlan
   • H. B. Haimes

   I. Cartilage degradation and osteoarthritis Pages: S129 - S130

10. Metalloprotease inhibitors halt collagen breakdown in IL-1 induced bovine nasal cartilage cultures

    • S. Spirito
    • J. Doughty
    • R. L. Goldberg

    I. Cartilage degradation and osteoarthritis Pages: S131 - S132

11. Antinociceptive activities of non-steroidal antiinflammatory drugs (NSAIDs) following intracerebroventricular (i.c.v.) and intrathecal (i.t.) administration in mice

    • T. L. Walter
    • T. T. Chau

    II. Lipid mediators Pages: S133 - S134

12. Identification and partial characterization of an acidic sphingomyelinase (SMase) from cultured human umbilical vein endothelial cells (HUVEC)

    • J. F. Truax
    • F. R. Cochran

    II. Lipid mediators Pages: S135 - S136

13. 3(S)-hydroxy-leukotriene B₄ is a potent granulocyte chemotaxin in the guinea pig dermis

    • D. Fretland
    • C. Anglin
    • J. Falck

    II. Lipid mediators Pages: S137 - S138

14. Differential involvement of protein kinase C in activating cytosolic phospholipase A₂ in alveolar macrophages and monocyte differentiated U937 cells

    • M. T. Withnall
    • A. M. Pennington
    • M. Hagen

    II. Lipid mediators Pages: S139 - S140

15. Effect of CGS 25019C and other LTB₄ antagonists in the mouse ear edema and rat neutropenia models

    • A. Raychaudhuri
    • B. Kotyuk
    • A. J. Main

    II. Lipid mediators Pages: S141 - S142

16. The pharmacokinetics and metabolism of SC-53228, a specific leukotriene B₄ receptor antagonist

    • S. Paulson
    • Y. Readus
    • D. Fretland

    II. Lipid mediators Pages: S143 - S144

17. A structural feature of N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulfonamide (NS-398) that governs its selectivity and affinity for cyclooxygenase 2 (COX2)

    • R. Huff
    • P. Collins
    • P. Isakson

    II. Lipid mediators Pages: S145 - S146

18. CGS 26529: The biological profile of a novel, orally active 5-lipoxygenase inhibitor with an extended duration of action

    • E. Kimble
    • T. Kowalski
    • J. van Duzer

    II. Lipid mediators Pages: S147 - S148

19. Role of induced nitric oxide synthase and increased NO levels in zymosan peritonitis in the rat

    • N. K. Boughton-Smith
    • A. Ghelani

    III. Nitric Oxide Pages: S149 - S150

20. Degradation of bovine cartilage proteoglycanin vitro is enhanced by inhibition of nitric oxide synthase

    • A. C. Hanglow
    • K. Rowan
    • J. W. Coffey

    III. Nitric Oxide Pages: S151 - S152

21. Role of inducible nitric oxide synthase (iNOS) and peroxynitrite in gut inflammation

    • N. D. Seago
    • D. A. Clark
    • M. J. S. Miller

    III. Nitric Oxide Pages: S153 - S154

22. Flow cytometric assessment of NADPH oxidase inhibitors in whole blood

    • W. Haston
    • J. H. van Duzer
    • J. C. Quintavalla

    III. Nitric Oxide Pages: S155 - S157

23. Activation of blood complement in guinea pigs receiving an intravenous injection of Sephadex beads

    • J. -F. Blain
    • K. Maghni
    • P. Sirois

    IV. New animal models of inflammatory diseases Pages: S158 - S159

24. Time-dependent cytokine production in the croton oil-induced mouse ear oedema and inhibition by prednisolone

    • H. Towbin
    • W. Pignat
    • I. Wiesenberg

    IV. New animal models of inflammatory diseases Pages: S160 - S161

25. A novel contact hypersensitivity model for rank-ordering formulated corticosteroids

    • S. C. Bailey
    • F. Asghar
    • E. S. Kurtz

    IV. New animal models of inflammatory diseases Pages: S162 - S163

26. Radiological assessment of relaxin-induced pubic symphyseal changes in guinea pigs: A model for screening disease modifying agents for osteoarthritis

    • P. A. Jimenez
    • B. G. Steinetz
    • H. B. Haimes

    IV. New animal models of inflammatory diseases Pages: S164 - S165

27. Granulocyte recruitment in guinea pig lungs following the administration of MBP-like cationic protein

    • D. Arseneault
    • K. Maghni
    • P. Sirois

    V. Pulmonary inflammation Pages: S166 - S167

28. Specific increase of microvascular permeability in lower airways of guinea pigs injected with Sephadex beads

    • S. Y. Martineau
    • K. Maghni
    • P. Sirois

    V. Pulmonary inflammation Pages: S168 - S169

29. Pulmonary pharmacology of WAY-126299A: A dual-acting 5-lipoxygenase inhibitor and leukotriene D₄ antagonist

    • R. E. Howell
    • L. P. Jenkins
    • D. Grimes

    V. Pulmonary inflammation Pages: S170 - S171

30. Pulmonary antiallergic and antiinflammatory effects of a novel, orallyactive phosphodiesterase IV inhibitor (WAY-127093B) in guinea pigs and rats

    • R. E. Howell
    • S. L. Woeppel
    • R. J. Heaslip

    V. Pulmonary inflammation Pages: S172 - S173

31. Relationship between the development of bronchial hyperresponsiveness and the airway eosinophilia in guinea pigs following injection with Sephadex beads

    • K. Maghni
    • M. J. Simard
    • P. Sirois

    V. Pulmonary inflammation Pages: S174 - S176

32. Differential modulation by betamethasone of allergen-induced cell influx and cell peroxidase in guinea-pig lungs

    • M. Yeadon
    • A. A. Petrovic
    • A. N. Payne

    V. Pulmonary inflammation Pages: S177 - S178

33. Sirolimus (rapamycin) inhibits mitogen-induced stimulation of protein synthesis in primary lymphocytes

    • C. C. Bansbach
    • D. Wancio
    • S. N. Sehgal

    VI. Lymphocyte activation/immunoregulation Pages: S179 - S180

34. The biochemical and pharmacological activity of 9-benzyl-9-deazaguanine, a potent purine nucleoside phosphorylase (PNP) inhibitor

    • E. Kimble
    • J. Hadala
    • P. Simon

    VI. Lymphocyte activation/immunoregulation Pages: S181 - S182

35. CP-123,369: A potent, orally active immunosuppressive agent

    • K. Koch
    • D. C. Hanson
    • B. M. Meiser

    VI. Lymphocyte activation/immunoregulation Pages: S183 - S184

36. Interferon-γ and antibodies to interleukin-5 and interleukin-4 inhibit the pulmonary eosinophilia in allergic mice

    • T. T. Kung
    • D. M. Stelts
    • R. W. Chapman

    VI. Lymphocyte activation/immunoregulation Pages: S185 - S186

37. Leflunomide: An active antiinflammatory and antiproliferative agent in models of dermatologic disease

    • E. S. Kurtz
    • S. C. Bailey
    • P. A. Przekop

    VI. Lymphocyte activation/immunoregulation Pages: S187 - S188

38. Comparison of effects of sirolimus on cytokine dependent and cytokine independent proliferation

    • K. L. Molnar-Kimber
    • A. Rhoad
    • S. N. Sehgal

    VI. Lymphocyte activation/immunoregulation Pages: S189 - S190

39. Evaluation of lymphocyte subsets in tamarins and marmosets

    • M. G. Petersen
    • B. Beegle
    • J. E. Fuhr

    VI. Lymphocyte activation/immunoregulation Pages: S191 - S192

40. The modified recalcification time (MRT) test assesses suppressive effect of general anesthesia (GA) on monocyte function

    • R. Ponnudurai
    • H. Ramasubramaniam
    • E. J. Lazaro

    VI. Lymphocyte activation/immunoregulation Pages: S193 - S193

41. Modulation of the immunoglobulin dysregulation in GvH- and SLE-like diseases by the murine IL-4 receptor (IL-4-R)

    • H. -U. Schorlemmer
    • G. Dickneite
    • K. -H. Enssle

    VI. Lymphocyte activation/immunoregulation Pages: S194 - S196

42. Endotoxin negates anticoagulant effect of cyclosporine

    • C. R. Spillert
    • S. Bonthu
    • E. J. Lazaro

    VI. Lymphocyte activation/immunoregulation Pages: S197 - S197

43. Heavy water activates monocyte generation of tissue factor

    • C. R. Spillert
    • R. N. Gonzales
    • E. J. Lazaro

    VI. Lymphocyte activation/immunoregulation Pages: S198 - S198

44. Anti-inflammatory activity of an orally active peptide sequence from PF-4 on acute inflammation and DTH

    • J. E. Talmadge
    • L. S. Kelsey
    • D. F. Counts

    VI. Lymphocyte activation/immunoregulation Pages: S199 - S200

45. Digoxin and endotoxin: A lethal pro-inflammatory combination

    • D. S. Tichansky
    • C. R. Spillert
    • E. J. Lazaro

    VI. Lymphocyte activation/immunoregulation Pages: S201 - S201

46. Modified recalcification time (MRT): A model to assess drug-induced depressed immune function

    • E. Wamsteker
    • C. R. Spillert
    • E. J. Lazaro

    VI. Lymphocyte activation/immunoregulation Pages: S202 - S202

47. Pharmacological inhibition of CD28-stimulated T cell activation

    • D. Wancio
    • N. K. Damle
    • C. C. Bansbach

    VI. Lymphocyte activation/immunoregulation Pages: S203 - S204

48. Sub-therapeutic doses of sirolimus and cyclosporin A in combination reduce SLE pathologies in the MRL mouse

    • L. M. Warner
    • T. Cummons
    • S. N. Sehgal

    VI. Lymphocyte activation/immunoregulation Pages: S205 - S206

49. Leflunomide, a reversible inhibitor of pyrimidine biosynthesis?

    • T. Zielinski
    • D. Zeitter
    • R. R. Bartlett

    VI. Lymphocyte activation/immunoregulation Pages: S207 - S208

50. Ultraviolet B-induced inflammatory cytokine production,in vivo: Initial pharmacological characterization

    • D. E. Griswold
    • M. N. Tzimas

    VII. Inflammatory cytokines Pages: S209 - S210